2026年第53卷第2期目录
| |
|
封面故事:多发性硬化症作为一种严重的中枢神经系统脱髓鞘疾病,目前的临床治疗手段多侧重
于免疫调节,但在促进髓鞘再生及遏制疾病慢性进展方面往往收效甚微。本研究另辟蹊径,聚焦
于“内源性甲醛蓄积”这一常被忽视的病理因素,探讨其作为治疗新靶点的潜力。研究团队利用
构建的慢性脱髓鞘小鼠模型,发现脑组织与脊髓中内源性甲醛浓度异常升高,同时小胶质细胞过
度活化、氧化应激增强及髓鞘损伤。针对普通虾青素水溶性差、难以进入脑组织的难题,研究设
计并制备了聚乙二醇修饰的纳米脂质体封装虾青素(PEG-ATX@NPs)。这种新型纳米制剂具备优
异的血脑屏障穿透能力,能够靶向作用于脑部并高效清除甲醛。实验结果表明,该纳米制剂通过
清除蓄积的甲醛,切断了神经炎症的恶性循环:它抑制了小胶质细胞向阿米巴样形态的病理性转
化,下调了促炎症因子的表达。本研究不仅证实了内源性甲醛是驱动多发性硬化症病理进展的关
键神经毒素,更为临床转化提供了一种非免疫依赖的创新策略,即通过纳米技术清除内源性甲醛
以抑制脱髓鞘,为多发性硬化症的治疗开辟了新的方向。
(吕万佳,曾鑫,童志前,邢杨,杨旭,武美娜,马萍. 纳米包装的虾青素通过消除过多内源性甲
醛改善多发性硬化模型小鼠脱髓鞘, 本期第442~457 页)
Cover Story:Objective Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system (CNS); however, its underlying neurological pathogenic mechanisms remain incompletely understood. Endogenous formaldehyde (FA), a metabolic byproduct of methylation-demethylation cycles, has recently been implicated in neurotoxicity, oxidative damage, and cognitive impairment. This study aimed to investigate whether excessive FA contributes to myelin sheath demyelination in mice and to evaluate the protective effects and mechanisms of two FA-elimination strategies: sodium bisulfite (NaHSO3), a classical FA scavenger, and polyethylene glycol-modified astaxanthin nanoparticles (PEG-ATX@NPs), a brain-targeted nano-antioxidant formulation.Methods A chronic demyelination model was established by feeding female C57BL/6J mice a diet containing 0.2% cuprizone (CPZ) for four weeks, followed by a two-week intervention period. Eighty mice were randomly assigned to four groups: NS (normal saline), CPZ+NS, CPZ+NaHSO3, and CPZ+PEG-ATX@NPs. Behavioral tests, including open-field, Y-maze, and pole-climbing assays, were conducted to assess locomotor activity, motor coordination, and working memory. FA levels in serum, corpus callosum, and spinal cord were measured using an Na-FA fluorescent probe and quantified via in vivo and ex vivo fluorescence imaging. Neuroinflammatory responses were evaluated by measuring TNF-α, IL-1β, and IL-6 levels using ELISA, while oxidative stress was assessed by reactive oxygen species (ROS) fluorescence intensity. Demyelination was examined via Luxol fast blue staining, and microglial activation was analyzed by Iba1 immunofluorescence. Correlation analyses were performed to explore relationships among FA levels, inflammatory cytokines, ROS intensity, and behavioral parameters.Results Compared with the NS group, mice in the CPZ+NS group exhibited significant weight loss, impaired motor coordination and memory, and markedly reduced myelin regeneration (P<0.05). FA levels and pro-inflammatory cytokines were significantly elevated in serum, corpus callosum, and spinal cord (P<0.05). FA-associated fluorescence in brain and spinal tissues, as well as ROS intensity across all tissues examined, also increased substantially (P<0.05). CPZ treatment induced pronounced microglial activation and severe demyelination in the corpus callosum (P<0.01). Both NaHSO3 and PEG-ATX@NPs effectively reduced FA accumulation in the brain and spinal cord, attenuated demyelination, suppressed microglial activation, decreased inflammatory cytokine levels, and improved motor and cognitive performance. These results confirm that CPZ induced severe demyelination accompanied by oxidative stress, neuroinflammation, and abnormal FA accumulation. Following intervention with either NaHSO3 or PEG-ATX@NPs, endogenous FA levels in the CNS were substantially reduced. Both treatments alleviated demyelination and significantly decreased the number of activated microglia. Levels of TNF-α, IL-1β, and IL-6 in serum, corpus callosum, and spinal cord were downregulated. Behavioral performance improved significantly, as evidenced by enhanced locomotor activity, better coordination, and improved memory function. These findings indicate that both FA-scavenging agents mitigate CPZ-induced biochemical and behavioral abnormalities.Conclusion This study demonstrates that excessive endogenous FA is closely associated with cognitive impairment, inflammatory dysregulation, and demyelination in a CPZ-induced chronic demyelination mouse model. Clearing abnormally elevated FA effectively reduces neuroinflammation, suppresses microglial overactivation, decreases oxidative stress, and alleviates demyelination, ultimately improving motor and cognitive outcomes in mice. These results suggest that targeting endogenous FA represents a promising therapeutic strategy for MS and other demyelinating disorders. Further investigations are warranted to explore the long-term safety, dosage optimization, and molecular pathways involved in FA-mediated neurotoxicity.
|
本期特稿
Highlights
综述与专论
研究快报
研究报告
动态与评论
|
|